摘要
目的 探究血清VCAM-1、miR-342-3p在乳腺癌手术前后的表达水平及其临床意义。方法 选取乳腺癌患者100例,收集患者临床资料。ELISA法检测患者手术前后血清VCAM-1水平以及RT-PCR检测miR-342-3p水平。结果 不同肿瘤大小、TNM分期、病理类型和淋巴结转移情况的乳腺癌患者术前血清VCAM-1、miR-342-3p表达水平差异均有统计学意义(P<0.05);不同年龄患者的术前血清VCAM-1、miR-342-3p表达水平比较,差异无统计学意义(P>0.05)。乳腺癌患者术后1周、1个月和6个月血清VCAM-1、miR-342-3p表达水平与术前相比均明显降低(P<0.05)。术前VCAM-1高表达组16个月累积生存率为70.4%,低于低表达组的90.2%(P<0.05);术前miR-342-3p高表达组16个月累积生存率为73.5%,低于低表达组的88.3%(P<0.05)。结论 乳腺癌患者血清VCAM-1、miR-342-3p表达水平在乳腺癌手术后明显下降。术前患者血清VCAM-1、miR-342-3p水平与病理特征及预后显著相关,可作为判断手术治疗效果的重要指标。
Objective To investigate the expression levels of serum VCAM-1 and miR-342-3p before and after breast cancer surgery and their clinical significance.Methods 100 patients with breast cancer were selected and their clinical data were collected.Serum VCAM-1 levels were detected by ELISA and miR-342-3p levels were detected by RT-PCR.Results There were significant differences in preoperative serum expression levels of VCAM-1 and miR-342-3p among breast cancer patients with different tumor size,TNM stage,pathological type and lymph node metastasis(P<0.05).There was no significant difference in the expression levels of serum VCAM-1 and miR-342-3p among patients of different ages before surgery(P>0.05).The expression levels of serum VCAM-1 and miR-342-3p in breast cancer patients at 1 week,1 month and 6 months after surgery were significantly decreased compared with those before surgery(P<0.05).The 16-month cumulative survival rate was 70.4%in the high VCAM-1 expression group,which was lower than 90.2%in the low expression group(P<0.05).Preoperative 16-month cumulative survival rate of miR-342-3p group was 73.5%,which was lower than 88.3%in Mir-342-3p group(P<0.05).Conclusion The expression levels of serum VCAM-1 and miR-342-3p in breast cancer patients decreased significantly after breast cancer surgery.Preoperative serum VCAM-1 and miR-342-3p levels of patients were significantly correlated with pathological characteristics and prognosis,which could be used as an important indicator to judge the therapeutic effect of surgery.
作者
杨婵婵
张文涛
乔龙飞
付琳琳
杨文辉
YANG Chanchan;ZHANG Wentao;QIAO Longfei(Zhengzhou Central Hospital Affiliated to Zhengzhou University,Zhengzhou,450000)
出处
《实用癌症杂志》
2023年第4期668-671,679,共5页
The Practical Journal of Cancer